Trial Profile
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Apr 2021
Price :
$35
*
At a glance
- Drugs Aspirin/dipyridamole (Primary)
- Indications Embolism and thrombosis; Vascular graft occlusion
- Focus Therapeutic Use
- Acronyms Graft
- 21 May 2009 Results published in the New England Journal of Medicine.
- 30 Apr 2008 New trial record.